Pharma news
Pharma
Law firm Schiff Hardin has added a life sciences specialist as a partner in its intellectual property group. 17 April 2015
Americas
A product of decomposing leaf litter, exDNA could be a powerful tool for interacting with biological systems. If so, the IP associated with its applications may be an active area in the coming years, says non-practising barrister Charles Brabin. 16 April 2015
Americas
The US Court of Appeals for the Second Circuit has heard arguments surrounding whether Actavis should be allowed to discontinue its first Alzheimer’s drug Namenda to make way for an extended release version of the medicine. 16 April 2015
Americas
The US Patent Trial and Appeal Board has instigated an interference proceeding between Biogen and Forward Pharma to determine who first invented a treatment for multiple sclerosis. 15 April 2015
Americas
Israeli pharmaceutical company Teva has, in one single filing, accused five generic drug makers of infringing a patent covering its blockbuster multiple sclerosis drug Copaxone. 14 April 2015
Americas
The US Court of Appeals for the Federal Circuit has upheld the validity of four patents covering conjunctivitis treatment AzaSite. 14 April 2015
Americas
Dallas-based hedge fund Hayman Capital Management has defended its owner’s decision to challenge a clutch of patents using the inter partes review procedure. 13 April 2015
Americas
The US Court of Appeals for the Federal Circuit has upheld a district court’s decision to invalidate a patent covering arthritis treatment Humira, after a challenge by biopharmaceutical company AbbVie. 9 April 2015
Americas
A US hedge fund manager and a company he created has taken aim at Jazz Pharmaceuticals in an inter partes review patent challenge, marking the third time he has challenged a company’s patents. 9 April 2015
Americas
Merck Sharp & Dohme has sued Apotex at the US District Court for the District of New Jersey for allegedly infringing a patent covering hay fever nasal spray Nasonex. 8 April 2015